Therapeutics - ACS (Acute Coronary Syndrome) Part 1 Flashcards
(67 cards)
acute coronary syndrome is also called
unstable angina
coronary artery disease (CAD) presents with ____
angina
why does CAD present with angina
due to atherosclerosis of the coronary vessels
what are the 3 categories of CAD
chronic stable
coronary artery vasospasm
ACS
3 subtypes of ACS
NSTEMI
unstable angina
STEMI
differentiate the EKG changes and biomarkers for:
-unstable angina
-NSTEMI
-STEMI
unstable angina - nonspecific EKG changes, no positive biomarkers (no myocardial injury)
NSTEMI - nonspecific EKG changes BUT there are positive biomarkers which indicates myocardial injury
STEMI - ST segment elevation on EKG AND positive biomarkers which indicates myocardial NECROSIS
differentiate between the symptoms of unstable angina vs NSTEMI vs STEMI
unstable angina and NSTEMI have the same clinical symptoms of angina
STEMI has these symptoms too, but women, elderly, and diabetics have an ATYPICAL REACTION – they dont get the classic gripping chest pain - get atypical symptoms like fatigue, back pain
true or false
in NSTEMI, there is no injury to the heart
FALSE- there is
have positive biomarkers
true or false
STEMI will lead to myocardial necrosis because there is TOTAL occlusion of the coronary artery
true
3 complications of ACS
cardiogenic shock
heart failure
left ventricle thrombus (very dangerous)
what are the 2 key things that we look for to determine the type of ACS?
be specific
EKG changes and cardiac biomarkers
cardiac biomarkers - we look to see if troponins and CK-MB (creatinine kinase) are elevated
in ECG, we look to see if ST is elevated specifically
invasive vs noninvasive diagnostic measures of ACS
invasive- cardiac catheterization
non-invasive - cardiac stress test
when a patient presents with ACS, what is important to obtain within 10 mins of presentation
ECG!!!!
determines STEMI or NSTEMI
risk stratification
true or false
even if a heart attack has resolved, troponins will still be elevated
true
cardiac biomarkers are secreted in response to….
injury or necrosis of muscle tissue
*target times for reperfusion when dealing with a STEMI patient
-give fibrinolytics within 12 hours of symptom onset (if more than 12 hours - DO NOT GIVE)
-do PCI within 120 minutes of symptom onset (door to needle time 30 mins ie - once pt gets to hospital, should get to cath lab within 30 mins)
-length of stay 4-5 days
TOTAL TIME FOR REPERFUSION NO MORE THAN 120 MINS!!! this is highest chance of survival
true or false
if it has been determined through EKG and cardiac biomarkers that the pt has STEMI, no further assessment is needed
TRUE - patient must directly go for reperfusion
true or false
fibrinolytics have NO ROLE in NSTEMI patients
TRUE
bc for NSTEMI we’re not dealing with a thrombus, but rather a platelet plug
true or false
the GRACE and TIMI scores are used for STEMI patients
FALSE
used for NSTEMI
for STEMI we do not stratify the risk - just directly reperfuse the patient
explain what we would do based on TIMI score:
high (5-7)
moderate (3-4)
low risk (0-2)
high risk (5-7) - invasive strategy. either PCI or CABG
moderate (3-4) - if they have high risk features, will be invasive (PCI/CABG)
if they do not have high risk features - will be conservative (ie - cardiac stress test)
low risk - will do stress test (noninvasive)
true or false
the longer we wait to reperfuse, the larger the area of injury/necrosis
true
what is an “ischemia-guided” strategy
AKA conservative strategy. NSTEMI pt has low risk TIMI score
4 words that show the approach to ACS treatment
modify (CV risk factors)
slow (progression athero.)
stabilize (plaques)
improve (balance between O2 demand and supply)
there is clinical suspicion of ACS
what 2 things are done STAT
LOADING DOSE OF aspirin (162-325mg CHEWED) and EKG within 10 mins of symptoms